Skip to content
TED Community
Menu

The Link Between Graves' Disease and Thyroid Eye Disease Explained

For many people, the terms Graves' disease and Thyroid Eye Disease (TED) are closely linked, and for good reason. Graves' disease is by far the most common cause of hyperthyroidism (an overactive thyroid gland) and is the primary underlying condition that leads to TED. Understanding this connection is vital for both managing thyroid health and addressing eye symptoms.

What is Graves' Disease?

Graves' disease is an autoimmune disorder. This means that the body's immune system, which is designed to fight off foreign invaders like bacteria and viruses, mistakenly attacks its own healthy tissues. In Graves' disease, the immune system produces antibodies, primarily Thyroid-Stimulating Immunoglobulins (TSIs), that mimic the action of Thyroid-Stimulating Hormone (TSH). These TSIs bind to TSH receptors on the thyroid gland, tricking it into producing excessive amounts of thyroid hormones (thyroxine/T4 and triiodothyronine/T3). This overproduction leads to the symptoms of hyperthyroidism, such as:

  • Rapid heartbeat

  • Weight loss despite increased appetite

  • Anxiety and irritability

  • Heat intolerance

  • Tremors

The Autoimmune Connection to Thyroid Eye Disease

The link between Graves' disease and TED lies in the shared autoimmune attack. While TSIs primarily target the thyroid gland, the immune system in Graves' disease also produces antibodies that can react with specific proteins found in the tissues behind the eyes. These proteins, particularly the TSH receptor and the Insulin-like Growth Factor 1 Receptor (IGF-1R), are present not only on thyroid cells but also on fat cells and fibroblasts (cells that form connective tissue) within the eye sockets (orbits). When these antibodies bind to the receptors in the orbital tissues, they trigger an inflammatory response. This inflammation leads to:

  • Swelling of the orbital fat and muscles: The muscles that move the eye (extraocular muscles) and the fat surrounding the eyeball become inflamed and swell.

  • Increased fluid accumulation: Water is drawn into the inflamed tissues.

  • Production of new fat cells and connective tissue: Fibroblasts are stimulated to produce more tissue.

All these changes lead to an increase in volume within the confined space of the eye socket, resulting in the characteristic symptoms of TED, such as:

  • Protrusion of the eyes (exophthalmos or proptosis): The eyeballs are pushed forward.

  • Eyelid retraction: The eyelids pull back, exposing more of the eye.

  • Double vision (diplopia): Due to the inflamed and stiffened eye muscles.

  • Redness, pain, and irritation: From ongoing inflammation.

Important Nuances in the Connection

While strongly linked, it's important to note some nuances:

  • TED can occur without overt hyperthyroidism: Approximately 10% of people with TED may have normal thyroid function (euthyroid Graves' ophthalmopathy) or even an underactive thyroid. In these cases, the autoimmune attack is still present, but it's primarily focused on the orbital tissues rather than causing significant thyroid dysfunction.

  • TED severity doesn't always parallel thyroid disease severity: A person with mild Graves' hyperthyroidism can have severe TED, and vice versa. The two conditions are manifestations of the same underlying autoimmune process but can run independent courses.

  • Thyroid treatment can impact TED: While treating Graves' hyperthyroidism is crucial for overall health, some treatments can affect TED. For instance, radioactive iodine (RAI) therapy for hyperthyroidism can sometimes worsen or trigger TED, especially in smokers. Close monitoring and sometimes prophylactic steroid use are considered in these cases. Antithyroid drugs (like methimazole) generally do not worsen TED and may even have a mild protective effect.

  • Smoking is a major risk factor: Smoking dramatically increases the risk of developing TED in individuals with Graves' disease and worsens its severity. It's believed to modify the immune response, making orbital tissues more susceptible to autoimmune attack.

In summary, Thyroid Eye Disease is a direct consequence of the autoimmune process characteristic of Graves' disease. While the thyroid gland is the primary target in Graves' hyperthyroidism, the eye tissues share common targets for the same misdirected immune response. Managing both the thyroid condition and the eye disease is critical for comprehensive care and improving patient outcomes.